Characterization of Nanoparticles Intended for Drug Delivery
Humana Press
Chapter title |
Considerations When Submitting Nanotherapeutics to FDA/CDER for Regulatory Review
|
---|---|
Chapter number | 3 |
Book title |
Characterization of Nanoparticles Intended for Drug Delivery
|
Published in |
Methods in molecular biology, January 2011
|
DOI | 10.1007/978-1-60327-198-1_3 |
Pubmed ID | |
Book ISBNs |
978-1-60327-197-4, 978-1-60327-198-1
|
Authors |
Katherine Tyner, Nakissa Sadrieh, Tyner, Katherine, Sadrieh, Nakissa |
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
Colombia | 1 | 3% |
Canada | 1 | 3% |
Egypt | 1 | 3% |
Unknown | 28 | 88% |
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 22% |
Student > Bachelor | 5 | 16% |
Student > Master | 5 | 16% |
Other | 3 | 9% |
Researcher | 3 | 9% |
Other | 4 | 13% |
Unknown | 5 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 19% |
Biochemistry, Genetics and Molecular Biology | 5 | 16% |
Chemistry | 5 | 16% |
Medicine and Dentistry | 4 | 13% |
Agricultural and Biological Sciences | 2 | 6% |
Other | 4 | 13% |
Unknown | 6 | 19% |